FR2122613A2 - - Google Patents

Info

Publication number
FR2122613A2
FR2122613A2 FR7202251A FR7202251A FR2122613A2 FR 2122613 A2 FR2122613 A2 FR 2122613A2 FR 7202251 A FR7202251 A FR 7202251A FR 7202251 A FR7202251 A FR 7202251A FR 2122613 A2 FR2122613 A2 FR 2122613A2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7202251A
Other versions
FR2122613B2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COMPREHENSIVE PHARMACEUT
Original Assignee
COMPREHENSIVE PHARMACEUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COMPREHENSIVE PHARMACEUT filed Critical COMPREHENSIVE PHARMACEUT
Publication of FR2122613A2 publication Critical patent/FR2122613A2/fr
Application granted granted Critical
Publication of FR2122613B2 publication Critical patent/FR2122613B2/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7202251A 1971-01-22 1972-01-24 Expired FR2122613B2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10901771A 1971-01-22 1971-01-22

Publications (2)

Publication Number Publication Date
FR2122613A2 true FR2122613A2 (fr) 1972-09-01
FR2122613B2 FR2122613B2 (fr) 1975-08-01

Family

ID=22325363

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7202251A Expired FR2122613B2 (fr) 1971-01-22 1972-01-24

Country Status (8)

Country Link
AU (1) AU458386B2 (fr)
BE (1) BE778334A (fr)
CA (1) CA963388A (fr)
DE (1) DE2202964A1 (fr)
FR (1) FR2122613B2 (fr)
GB (1) GB1368201A (fr)
IE (1) IE35991B1 (fr)
ZA (1) ZA72423B (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0439640A1 (fr) * 1990-01-29 1991-08-07 WOGEPHARM GmbH Méthode de preparation d'agents pour la thérapie de maladies de la peau
WO1994022421A2 (fr) * 1993-04-02 1994-10-13 Wogepharm Gmbh Utilisation de sels de magnesium solubles dans l'eau dans des preparations topiques et nouvelles preparations composees
FR2732602A1 (fr) * 1995-04-10 1996-10-11 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique ou pharmaceutique pour traiter les prurits
FR2732601A1 (fr) * 1995-04-10 1996-10-11 Oreal Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene
FR2732600A1 (fr) * 1995-04-10 1996-10-11 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique et/ou dermatologique et composition obtenue
FR2732599A1 (fr) * 1995-04-10 1996-10-11 Oreal Utilisation de sels de metaux alcalino-terreux comme inhibiteurs de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
EP0799018A1 (fr) * 1994-12-21 1997-10-08 Cosmederm Technologies Formulations et procedes pour diminuer l'irritation de la peau
EP0801554A1 (fr) * 1994-12-21 1997-10-22 Cosmederm Technologies Formulations et procedes pour diminuer l'irritation de la peau
US5851556A (en) * 1995-04-10 1998-12-22 Societe L'oreal S.A. Use of a salt of an alkaline-earth metal as TNF-A or substance P inhibitor in a topical composition and composition obtained
US5866168A (en) * 1995-10-26 1999-02-02 Societe L'oreal S.A. Dermatological/pharmaceutical compositions comprising lanthanide, manganese, tin, zinc, yttrium, cobalt, barium and/or strontium salts as substance P antagonists
US5900257A (en) * 1995-10-26 1999-05-04 Societe L'oreal S.A. Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
EP4014962A1 (fr) * 2020-12-16 2022-06-22 Novigo GmbH & Co. KG Composition comprenant une substance à action osmotique et utilisation de la composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0439640A1 (fr) * 1990-01-29 1991-08-07 WOGEPHARM GmbH Méthode de preparation d'agents pour la thérapie de maladies de la peau
WO1994022421A2 (fr) * 1993-04-02 1994-10-13 Wogepharm Gmbh Utilisation de sels de magnesium solubles dans l'eau dans des preparations topiques et nouvelles preparations composees
WO1994022421A3 (fr) * 1993-04-02 1994-11-24 Wogepharm Gmbh Utilisation de sels de magnesium solubles dans l'eau dans des preparations topiques et nouvelles preparations composees
US5679359A (en) * 1993-04-02 1997-10-21 Wogepharm Gmbh Water-soluble magnesium salts in externally applicable formulations and new combination preparations
EP0801554A1 (fr) * 1994-12-21 1997-10-22 Cosmederm Technologies Formulations et procedes pour diminuer l'irritation de la peau
US6455076B1 (en) 1994-12-21 2002-09-24 Gary S. Hahn Formulations and methods for reducing skin irritation
EP0799018A4 (fr) * 1994-12-21 2000-03-29 Cosmederm Technologies Formulations et procedes pour diminuer l'irritation de la peau
EP0801554A4 (fr) * 1994-12-21 2000-03-29 Cosmederm Technologies Formulations et procedes pour diminuer l'irritation de la peau
EP0799018A1 (fr) * 1994-12-21 1997-10-08 Cosmederm Technologies Formulations et procedes pour diminuer l'irritation de la peau
FR2732601A1 (fr) * 1995-04-10 1996-10-11 Oreal Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene
US5851556A (en) * 1995-04-10 1998-12-22 Societe L'oreal S.A. Use of a salt of an alkaline-earth metal as TNF-A or substance P inhibitor in a topical composition and composition obtained
FR2732599A1 (fr) * 1995-04-10 1996-10-11 Oreal Utilisation de sels de metaux alcalino-terreux comme inhibiteurs de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
FR2732600A1 (fr) * 1995-04-10 1996-10-11 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique et/ou dermatologique et composition obtenue
FR2732602A1 (fr) * 1995-04-10 1996-10-11 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique ou pharmaceutique pour traiter les prurits
US5866168A (en) * 1995-10-26 1999-02-02 Societe L'oreal S.A. Dermatological/pharmaceutical compositions comprising lanthanide, manganese, tin, zinc, yttrium, cobalt, barium and/or strontium salts as substance P antagonists
US5900257A (en) * 1995-10-26 1999-05-04 Societe L'oreal S.A. Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists

Also Published As

Publication number Publication date
GB1368201A (en) 1974-09-25
AU458386B2 (en) 1975-02-10
ZA72423B (en) 1972-10-25
CA963388A (en) 1975-02-25
DE2202964A1 (de) 1972-08-10
FR2122613B2 (fr) 1975-08-01
AU3824272A (en) 1973-07-26
IE35991B1 (en) 1976-07-21
IE35991L (en) 1972-07-22
BE778334A (fr) 1972-05-16

Similar Documents

Publication Publication Date Title
FR2122613B2 (fr)
ATA136472A (fr)
AR196074A1 (fr)
AU2691671A (fr)
AU3005371A (fr)
AU2742671A (fr)
AU2894671A (fr)
AU2941471A (fr)
AU2952271A (fr)
AU2880771A (fr)
AU2938071A (fr)
AU2684171A (fr)
AU3038671A (fr)
AU3025871A (fr)
AR192311Q (fr)
AU2706571A (fr)
AR199640Q (fr)
AR202997Q (fr)
AU2724971A (fr)
AU2963771A (fr)
AU2726271A (fr)
AU1109576A (fr)
AU2740271A (fr)
AU2755871A (fr)
AU2399971A (fr)